Universal Health Realty Income Trust (UHT) - Q2 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025. Universal Health Realty Income Trust (UHT) is a real estate investment trust (REIT) investing in healthcare and human-service facilities, including acute care hospitals, behavioral health hospitals, medical office buildings, and free-standing emergency departments. The Trust is advised by a wholly-owned subsidiary of Universal Health Services, Inc. (UHS), which also serves as a major tenant.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Total Revenues | $24.9 million | $24.7 million | $49.4 million | $49.9 million |
| Net Income | $4.5 million | $5.3 million | $9.3 million | $10.6 million |
| Diluted EPS | $0.32 | $0.38 | $0.67 | $0.76 |
| Funds From Operations (FFO) | $11.8 million | $12.4 million | $23.7 million | $24.8 million |
| FFO per Diluted Share | $0.85 | $0.90 | $1.71 | $1.79 |
| Operating Cash Flow (YTD) | $25.3 million (2025) vs $23.9 million (2024) | |||
| Total Debt Outstanding | $373.5 million ($354.8M Credit Facility + $18.7M Mortgages) | |||
| Cash and Equivalents | $6.6 million (as of June 30, 2025) | |||
| Dividends Paid (YTD) | $20.5 million ($1.475 per share) |
Material Changes vs. Prior Period
- Net Income Decline: Net income decreased by $0.8 million (15%) in Q2 2025 compared to Q2 2024. The primary drivers were a one-time $0.6 million property tax reduction recorded in Q2 2024 (not present in 2025) and a $0.1 million increase in interest expense due to higher average borrowings.
- Revenue Stability: Total revenues increased slightly by $0.1 million in Q2 2025 but decreased by $0.5 million on a year-to-date basis, primarily due to decreased occupancy rates at certain medical office buildings (MOBs) in the first quarter.
- Interest Expense: Net interest expense increased by $0.1 million in Q2 2025. This was driven by a reduction in interest rate swap income (due to the expiration of lower-rate swaps in late 2024 and replacement with higher-rate swaps), partially offset by a lower effective cost of borrowings on the credit facility.
- Debt Structure: The Trust amended its Credit Agreement in September 2024, increasing capacity to $425 million and extending maturity to 2028. Outstanding borrowings on the facility increased to $354.8 million as of June 30, 2025.
Guidance, Outlook, and Risks
Management Commentary: Management maintains that operating cash flows are sufficient to fund dividend payments and capital requirements. The Trust expects to finance future capital expenditures and acquisitions through internally generated funds, available borrowing capacity ($70.2 million remaining on the credit facility), or potential equity/debt issuances.
Key Risks and Contingencies:
- Legislative Impact (Medicaid): The filing highlights the "One Big Beautiful Bill Act" adopted July 4, 2025, which imposes work requirements for Medicaid eligibility and limits provider fees. This is expected to reduce revenues for operators like UHS and increase uncompensated care, potentially impacting UHT's rental income.
- Tenant Concentration: Approximately 40% of consolidated revenues are derived from UHS-related tenants. Lease renewals or purchase options exercised by UHS could materially impact future revenue streams.
- Interest Rate Sensitivity: A 1% change in interest rates would impact net income by approximately $1.9 million. The Trust has active interest rate swaps totaling $165 million notional amount to hedge variable rate debt.
- Unconsolidated Investments: The Trust holds non-controlling interests in four LLCs/LPs. While these entities are generally self-sustaining, the Trust may be required to provide funding for capital expenditures or debt service.
Investor Verification Checklist
- Verify the impact of the July 2025 Medicaid legislation on UHS's financial health and ability to pay rent.
- Review the lease expiration schedule for the six UHS hospital facilities, noting that two expire in December 2026.
- Monitor the occupancy rates of medical office buildings (MOBs), which contributed to the YTD revenue decline.
- Assess the sufficiency of the $70.2 million available borrowing capacity against upcoming capital commitments and debt maturities.
- Confirm the status of the vacant specialty facility in Evansville, Indiana, and the vacant land in Chicago, Illinois, regarding ongoing operating expenses.